All countries around the world unite again to discuss issues about the world drug problem in the United Nations General Assembly Special Session on Drugs in New York City, USA from 19-21 April 2016.
Dangerous Drugs Board (DDB) Chairman Sec. Felipe L. Rojas Jr., together with Permanent Board Member Usec. Edgar C. Galvante, and other officials from the Board’s member agencies such as the Department of Justice (DOJ), Department of Health (DOH), and the Philippine Drug Enforcement Agency (PDEA) form part of the Philippine delegation to the forum where they will also report on the country’s drug prevention and control accomplishments and plans to address new issues and challenges on the anti-drug fight.
Among the most pressing concerns that the assembly will discuss are the development and implementation of strategies anchored on human rights-based approaches and identification of effective responses to social and health impacts of drugs.
In line with this, the Philippine delegation will report on the institutionalization of the country’s National Anti-Drug Plan of Action or NADPA, a comprehensive plan that balances supply and demand reduction efforts, strengthening preventive education programs as well as treatment and rehabilitation services. It also promotes alternative development, elicits social response and facilitates regional and international cooperation.
UN convenes a special session on the world drug problem to review progress in the implementation of the Political Declaration and Plan of Action on International Cooperation towards an integrated and balanced strategy to counter the world drug problem. It is also a way of assessing the achievements and challenges in countering the world drug problem, within the framework of the three (3) international drug control conventions and other relevant United Nations instruments.
Responding to requests of legitimate industries led by Samahan sa Pilipinas ng Industriyang Kemika, the Dangerous Drugs Board has decided to extend the moratorium on the ban of spray paints and glue with toluene concentrations equal to or higher than 0.1% by weight.
A regulation issued by the DDB in 2014 which took effect on March 13, 2015 banned the sale of toluene-based spray paints and glue to the general public. This move was made to address the increasing incidents of abuse of toluene-based inhalants.
However, recognizing the legitimate use of toluene by manufacturers and other industries, the DDB has issued a moratorium on the implementation of this provision. Legitimate users are given a one-year moratorium which ended on March 12, 2016.
Since January, the DDB has been receiving requests for the extension of this moratorium and during its 168th meeting on April 13, 2016, the Board has approved a resolution extending the moratorium until September 30, 2016.
This was after a careful evaluation and recommendation of a Technical Working Group and consideration of the principle that regulations should not hamper the operations of legitimate industries.
During the meeting, Usec. Edgar C. Galvante, DDB Permanent Member, raised the motion to grant the extension. It was seconded by Usec. Alberto T. Muyot, ex-officio member representing the Secretary of the Department of Education. With the members of the Board having no objection, DDB Chairman Sec. Flipe L. Rojas, Jr., granted the motion.
Aside from extending this moratorium, the Board during its meeting has also approved the grant of subsistence allowance for patients in drug treatment and rehabilitation centers in Bataan, Caraga, Argao and Malinao.
As the policy-making and strategy-formulating body on drug prevention and control, the DDB has the power to issue regulations or resolutions that have the effect of a law. These are deliberated during meetings conducted regularly with members of the Board.
The 168th Board Meeting is the first meeting presided by Sec. Rojas, the newly appointed Chairman of the Board.
Sec. Felipe L. Rojas, Jr., Dangerous Drugs Board (DDB) Chairman, has recently met with heads of the Department of National Defense (DND), Integrated Bar of the Philippine (IBP) and the Department of Health (DOH).
Appointed in February, the new DDB chair has been making a round of courtesy calls to heads of concerned agencies and organizations to further strengthen collaboration in the fight against drugs.
Discussions focused on the implementation of the National Anti-Drug Plan of Action or NADPA, which outlines the plans and strategies of the government in addressing the country’s drug problem.
DND Secretary Voltaire T. Gazmin, IBP President Atty. Rosario Reyes and DOH Secretary Janette L. Garin assured the DDB chair of their support to the anti-drug fight through the fulfillment of their respective roles and responsibilities in the NADPA.
Based on the NADPA, the DND is tasked to assist in the development of policies that will support law enforcement initiatives. IBP’s responsibility is to support the Board in the formulation and review of regulations and resolutions.
Given the health impact of drug use, the DOH has been tasked with a number of responsibilities. Among these are to oversee tertiary prevention or treatment and rehabilitation programs, supplement demand reduction efforts, enhance access to controlled medications, assist in the collection of drug-related data, conduct studies and monitor effects of dangerous drugs on peoples’ heath.
Sec. Rojas has regarded the support and cooperation of the entire government as a key element in the campaign against drugs. As what he always says, “all of us should unite to free our country from drugs.”
He is set to meet with other officials in the coming weeks and during the meeting of DDB’s member agencies in April 13, the first meeting he will preside as Chairman of the DDB.
The Dangerous Drugs Board (DDB) has gained more allies in the campaign against drugs through senior citizens’ group.
In a concluded seminar for Drug Abuse Prevention Education for Senior Citizens held at Ciudad Christia Resort, San Mateo Rizal on April 4-5, 2016, the group of senior citizens pledged their support to the government’s fight against drugs.
Among the participants of the seminar are retired government employees and members of different senior citizens’ associations.
Mrs. Matilde Prudenciado, a member of the Association of DOH Retired Employees and participant to the seminar, said that their role in the society, especially in the battle against drug abuse did not stop when they retired.
“We are attending this seminar in order to have additional knowledge about drug abuse prevention that will eventually be imparted to our community starting from our family, our children and grandchildren,” Mrs. Prudenciado said.
As participants of the seminar, they are trained to conduct re-echo seminars that will educate the members of their community.
“Compared to other drug advocates, we, the senior citizens, are more experienced in this field that makes it our advantage to help the country spread the advocacy against illegal drugs,” Mrs. Prudenciado explained.
“We are only retired from our government work, but we are not retiring from our role of imparting to the next generation how drugs affect the health and safety of our communities,” she added.
At the age of 64, Mrs. Prudenciado continue to attend seminars on drug abuse prevention education because for her, being a drug advocate has no age requirement. Everyone can contribute to the efforts of freeing our country from the evils of drugs.
At least 200 students from different colleges and universities all over the country gathered in Cebu City on 29-31 March 2016 for the 3-day national convention on drug abuse prevention education spearheaded by the Dangerous Drugs Board (DDB) in coordination with the Commission on Higher Education (CHED) and the non-government organization, Association of Advocates Against Drugs or A3D.
To all concerned clients and stakeholders:
The Legal Division of the Dangerous Drugs Board receives numerous requests for Certificate of No Controlled Chemicals and Certificate of Exemption. In a bid to efficiently process and proficiently evaluate all these requests, we will be implementing a schedule for the submission of applications and walk-in inquiries.
Starting on 20 July 2015 (Monday), submission of applicants and walk-in inquiries shall be accommodated by our personnel from 8:00 AM to 2:00 PM on regular office days. This will allow us to process applications thereafter.
We are hoping for your understanding and cooperation.
Dangerous Drugs Board
To all Physicians, Dentists, Veterinarians, or Practitioners:
The Department of Health-Special Concerns Technical Cluster-Dangerous Drug Abuse Prevention and Treatment Program (SCTC-DDAPTP) announces the availability of Yellow Prescription Pads for sale at selected DOH distribution sites. (Please see complete list under Downloads section in the side bar portion of the DDB website).
FOR: APPLICANTS FOR ISSUANCE OF CERTIFICATE OF NON-CONTROLLED CHEMICALS AND CERTIFICATE OF EXEMPTION
FROM: DDB LEGAL
Effective February 4, 2015 (Wednesday), all applications and attached annexes for certificate of non-controlled chemicals and certificate of exemtion shall submitted in pdf format of said application and attached annexes to be placed in a CD or USB Flash Drive. The requirement aims to improve file management and reduce paper usage in the office.
Applications submitted after the said date without the soft copy requirement shall not be accepted.
Thank you for your cooperation.
Please enclose a SELF - ADDRESSED STAMPED ENVELOPE if you wish to have your certification / exemption mailed to your company through registered mail only. Please ensure that you have placed the proper amount of stamps in a legal - size envelope in order to have the certification / exemption delivered through registerd mail.
TO: ALL PHYSICIANS, DENTISTS, VETERINARIANS AND PHARMACISTS
In the interest of public service, please be informed that due to unavailability of the DOH-Special Prescription Form (Yellow Pad), the use of Ordinary Personalized Prescription Form is HEREBY EXTENDED UNTIL SUCH TIME THE DOH SPECIAL PRESCRIPTION FORMS shall be readily available.
Furthermore, the same shall be in triplicate form, the ordinary copy of which shall be surrendered to the drugstore or pharmacy that dispense the dangerous drugs, the duplicate copy shall remain with the patient or purchaser-representative, and the third copy shall be retained by the prescribing physician.
This advisory shall take effect immediately.
(Sgd) Undersecretary JOSE MARLOWE S. PEDREGOSA
05 April 2013